Hepion Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2…

Biotechnology
US, Edison [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of HEPA's Analysis
CIK: 1583771 CUSIP: 426897104 ISIN: US4268973025 LEI: - UEI: -
Secondary Listings
HEPA has no secondary listings inside our databases.